Biogen Inc.
BIIB
$181.54
$0.790.43%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.07B | 10.00B | 9.82B | 9.68B | 9.61B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.07B | 10.00B | 9.82B | 9.68B | 9.61B |
| Cost of Revenue | 2.62B | 2.70B | 2.71B | 2.63B | 2.66B |
| Gross Profit | 7.45B | 7.30B | 7.11B | 7.05B | 6.95B |
| SG&A Expenses | 2.43B | 2.41B | 2.38B | 2.39B | 2.31B |
| Depreciation & Amortization | 486.10M | 460.50M | 420.00M | 386.50M | 351.90M |
| Other Operating Expenses | 277.40M | 259.50M | 246.90M | 254.40M | 251.60M |
| Total Operating Expenses | 7.18B | 7.28B | 7.21B | 7.12B | 7.09B |
| Operating Income | 2.88B | 2.72B | 2.61B | 2.56B | 2.51B |
| Income Before Tax | 1.90B | 1.80B | 1.75B | 1.91B | 1.91B |
| Income Tax Expenses | 295.50M | 267.20M | 273.10M | 273.80M | 291.70M |
| Earnings from Continuing Operations | 1.61K | 1.53K | 1.48K | 1.63K | 1.61K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | 800.00K |
| Net Income | 1.61B | 1.53B | 1.48B | 1.63B | 1.62B |
| EBIT | 2.88B | 2.72B | 2.61B | 2.56B | 2.51B |
| EBITDA | 3.65B | 3.46B | 3.32B | 3.23B | 3.14B |
| EPS Basic | 10.99 | 10.48 | 10.15 | 11.21 | 11.11 |
| Normalized Basic EPS | 11.53 | 10.73 | 10.29 | 9.97 | 9.80 |
| EPS Diluted | 10.96 | 10.45 | 10.12 | 11.18 | 11.07 |
| Normalized Diluted EPS | 11.50 | 10.70 | 10.26 | 9.93 | 9.77 |
| Average Basic Shares Outstanding | 584.90M | 584.00M | 583.10M | 582.20M | 581.40M |
| Average Diluted Shares Outstanding | 586.50M | 585.50M | 584.70M | 584.00M | 583.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |